AI assistant
Sending…
AIM ImmunoTech Inc. — Director's Dealing 2017
Feb 21, 2017
35334_dirs_2017-02-21_e59ec984-e805-4dc2-a467-6660eff3f489.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4/A — Form 4/A
Issuer: HEMISPHERX BIOPHARMA INC (HEB)
CIK: 0000946644
Period of Report: 2017-02-16
Reporting Person: Springate Wayne S. (Sr VP of Operations)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2017-02-16 | Common Stock | P | 8014 | $0.46 | Acquired | 16641 | Direct |
Footnotes
F1: The amount of securities beneficially owned following the reported transaction was incorrect when filed earlier today (2/21/17).